Quidel Receives FDA Clearance for Its New Solana® Molecular Assay

News   Nov 30, 2016

 
Quidel Receives FDA Clearance for Its New Solana® Molecular Assay
 
 
 

RELATED ARTICLES

Blood Test Predicts Prostate Tumor Resistance

News

A new blood test developed by researchers at the Technical University of Munich (TUM) can predict drug resistance in patients with advanced prostate cancer.

READ MORE

Biofortuna Raises £1.6 Million in Funding Round

News

Biofortuna Ltd has raised £1.6 million, allowing the company to take its blood group genotyping assays into clinical trails and commercialisation.

READ MORE

UVA Health Enlists Robotic Help to Enhance Blood Testing

News

The system has revolutionized how it tests patient blood samples, automating its primary testing facility with high-tech robots that are getting doctors the results they need quickly and efficiently – and allowing UVA to offer a wider range of blood tests, to boot.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE